Ziprasidone vs olanzapine in schizophrenia: a 6-month extension study

被引：0
|
作者：
Simpson, G
Horne, RL
Weiden, P
Pigott, T
Bari, M
Romano, SJ
机构：
[1] Synergy Clin Res Ctr, Crula Vista, CA USA
[2] Univ Florida, Clin Trials Program, Gainesville, FL USA
[3] SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA
[4] Lake Mead Hosp, Las Vegas, NV USA
[5] Univ So Calif, Keck Sch Med, Los Angeles, CA USA
来源：
EUROPEAN PSYCHIATRY | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：186S / 187S
页数：2
相关论文
共 50 条
  • [1] Ziprasidone vs olanzapine in schizophrenia: 6-Month continuation study
    Simpson, GM
    Weiden, P
    Pigott, T
    Romano, SJ
    Siu, C
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S311 - S311
  • [2] Ziprasidone vs. olanzapine in schizophrenia: 6-month cognitive data
    Harvey, PD
    Cohen, G
    Loebel, A
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 205 - 205
  • [3] Analysis of remission in a 6-month double-blind continuation study of ziprasidone vs olanzapine
    Masand, P. S.
    Loebel, A. D.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S273 - S273
  • [4] Cognitive improvement and neuropsychological normalization with ziprasidone or olanzapine: Results of a 6-month study
    Harvey, PD
    Bowie, CR
    Loebel, A
    Warrington, L
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S294 - S294
  • [5] Cognitive improvement in schizophrenia after 6-month treatment with olanzapine
    Krysta, K.
    Klasik, A.
    Krupka-Matuszczyk, I.
    Przybylo, J.
    Janas-Kozik, M.
    Sygut, M.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S121 - S121
  • [6] Ziprasidone vs olanzapine for cognitive function in schizophrenia
    Harvey, P
    Simpson, GM
    Loebel, A
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S293 - S293
  • [7] Ziprasidone vs olanzapine for cognitive function in schizophrenia
    Harvey, PD
    Simpson, G
    Horne, R
    Weiden, PJ
    Bari, M
    Romano, SJ
    [J]. EUROPEAN PSYCHIATRY, 2002, 17 : 100S - 100S
  • [8] Ziprasidone versus olanzapine in schizophrenia: Six-month continuation study
    Simpson, GM
    Weiden, P
    Pigott, T
    Romano, SJ
    Siu, C
    [J]. SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 303 - 303
  • [9] Assessing cardiovascular risks of olanzapine treatment: a 6-month study versus haloperidol in schizophrenia patients
    Barak, Y
    Swartz, M
    Plopsky, I
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (06) : 315 - 317
  • [10] Effectiveness of Lurasidone for Patients With Schizophrenia Following 6 Weeks of Acute Treatment With Lurasidone, Olanzapine, or Placebo: A 6-Month, Open-Label, Extension Study
    Stahl, Stephen M.
    Cucchiaro, Josephine
    Simonelli, Doreen
    Hsu, Jay
    Pikalov, Andrei
    Loebel, Antony
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (05) : 507 - 515
12345